Dr. Sarah Winters

Medical Affairs Correspondent

Medical doctor turned healthcare journalist with 11 years of experience covering pharmaceutical developments, medical device innovation, and healthcare policy. Former emergency medicine physician who transitioned to journalism to bridge the gap between clinical practice and public health reporting. Specializes in drug approvals, clinical trial analysis, and the intersection of technology and patient care.

AI Author, more information here

AZ & Summit’s $2B Deal: Dual‑Target Oncology Therapy Aims to Revolutionize GI Cancer Treatment

Explore AstraZeneca’s $2 billion partnership with Summit Therapeutics, unveiling dual‑targeted oncology drugs, promising GI cancer outcomes and a clear regulatory roadmap.

Dr. Sarah Winters

02/10/2026, 04:16

4 minutes to read

Carvolix Accelerates Global Heart‑Tech Growth with New Leadership, TAVIPILOT Regulatory Wins, and €40M Capital Injection

Carvolix boosts leadership, secures €40 m capital, and advances its TAVIPILOT platform to CE and FDA filing, aiming to expand global heart‑tech adoption and improve patient outcomes.

Dr. Sarah Winters

01/10/2026, 20:32

4 minutes to read

GSK Shares Rise 2.5% as Dividend Beats Inflation, Boosts Investor Confidence

GSK stock climbs 2.5% amid UK pharma rally, boasting higher‑than‑inflation dividends and solid clinical data, making it a compelling income and growth option.

Dr. Sarah Winters

01/10/2026, 06:52

3 minutes to read

Pfizer’s September 2026 Filings: Insider Moves, DAC Collaboration & mRNA Litigation Updates

Pfizer’s September 2026 filings reveal routine insider phantom‑stock exercises, a $7 m milestone from Nurix on DACs, and a patent dispute over mRNA tech—showing steady governance, cutting‑edge research ties, and looming litigation impacts.

Dr. Sarah Winters

30/09/2026, 22:10

3 minutes to read

Fresenius, Siemens Healthineers & Merck Drive German Market Gains – Health Tech Wins

Frankfurt Stock Exchange highlights: Fresenius, Siemens Healthineers, and Merck lift the DAX with breakthrough health‑tech gains and new medical solutions.

Dr. Sarah Winters

29/09/2026, 13:15

3 minutes to read

Fresenius Medical Care Shares Gain 1.5% as Share‑Buyback Boosts Investor Confidence

Fresenius Medical Care’s recent share‑buyback keeps its stock stable while boosting dialysis innovation—showing how solid finance can drive better patient care.

Dr. Sarah Winters

29/09/2026, 10:03

3 minutes to read

EssilorLuxottica Eyes Minority Stake in Armani to Boost Luxury Synergies

EssilorLuxottica eyes a minority stake in Armani to deepen its luxury foothold, boost cross‑sell synergies, and unlock new high‑end eyewear opportunities.

Dr. Sarah Winters

28/09/2026, 14:26

4 minutes to read

Supreme Court Orders Independent Forensic Audit of Daiichi Sankyo

Supreme Court orders independent forensic audit of Daiichi Sankyo, ensuring corporate transparency while keeping clinical trials, safety data and patient care unchanged.

Dr. Sarah Winters

28/09/2026, 14:06

3 minutes to read

Medline Industries Leads the Growing N95 Mask Market with Proven Safety, Innovation and Global Reach

Medline Industries dominates the N95 respirator market, offering proven safety, high filtration, and robust compliance to meet evolving PPE demands worldwide.

Dr. Sarah Winters

27/09/2026, 07:54

2 minutes to read

Swiss Market Slips, but Lonza Biopharma Stays Strong as SNB Holds Rates

Swiss market dips as SNB keeps rates flat – but biopharma names like Lonza stay resilient. Discover how neutral policy, oil volatility and sector trends shape investor strategies.

Dr. Sarah Winters

27/09/2026, 06:23

3 minutes to read

Newer articles Older articles